|
|
 |
|
Viewing report
|
|
|
|
Epidemiology: Endometrial Cancer
Datamonitor, March 2011, Pages: 24
Endometrial cancer is the most common gynecological cancer in the developed world and the fourth most common malignancy among women. Just over 82,000 women will be diagnosed with endometrial cancer in the seven major markets in 2010. Postmenopausal women in particular are at risk for endometrial cancer, having 10 times the risk of premenopausal women.
Scope of the report:
- Gain insight to market potential, including a robust 10-year epidemiology forecast of endometrial cancer incident cases.
- Understand the key epidemiologic risk factors associated with enometrial cancer.
Highlights:
- Between 2010 and 2019 total endometrial cancer incident cases in the seven major markets are forecasted to increase by 17%. Significant growth is expected in incident cases in Japan. This growth of almost 30% over the forecast period is most likely a combination of continued increasing trends of endometrial cancer and the aging population.
- Growth in the EU markets ranges from roughly 11% (Italy) to 22% (UK). When all five countries are taken together, the expected growth over the forecast period is almost 14%. Interestingly, lower growth rates will occur in the markets with greater numbers of incident cases, suggesting a plateau in the number of incident endometrial cancer cases.
Reasons to buy:
- What are the most robust sources for endometrial cancer incidence?
- How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
- How do changes in the population structure and risk factors affect the trend in incident endometrial cancer cases?
|
|
|
|
